A Simple Key For GM-CSF/CSF2 Protein Unveiled
123). It really is noteworthy that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for lack of Gls in MYC-induced mouse liver tumours40. This means that GLS2 could confer resistance to GLS1-specific inhibitors, including the allosteric inhibitor BPTES or CB-839, which resistance can be hypothetically avoided by the usag